Alessandro Pezzini Selected Research

Alessandro Pezzini Research Topics

Disease

40	Stroke (Strokes) 12/2023 - 03/2002
30	Ischemic Stroke 12/2023 - 03/2002
12	Atrial Fibrillation 02/2024 - 01/2012
9	Blood Vessel Dissection 05/2023 - 01/2002
9	Hemorrhage 01/2022 - 08/2015
7	Cerebral Hemorrhage 02/2024 - 11/2016
6	COVID-19 07/2022 - 01/2020
5	Hypertension (High Blood Pressure) 10/2021 - 02/2004
5	Migraine Disorders (Migraine) 01/2021 - 04/2006
4	Brain Ischemia (Cerebral Ischemia) 09/2021 - 01/2007
4	Myocardial Infarction 03/2015 - 01/2004
3	Leukocytosis (Pleocytosis) 10/2022 - 01/2020
3	Infections 10/2021 - 01/2014
3	Hematoma 01/2020 - 02/2014
2	Thrombosis (Thrombus) 02/2024 - 06/2017
2	Hypercholesterolemia 02/2024 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2020
2	Pulmonary Embolism 01/2020 - 09/2012
2	Fibromuscular Dysplasia 06/2019 - 01/2014
2	Infarction (Infarctions) 05/2019 - 03/2012
2	Embolic Stroke 01/2019 - 08/2015
2	Migraine with Aura (Familial Hemiplegic Migraine) 01/2019 - 04/2014
2	Leukoaraiosis 01/2019 - 03/2017
2	Embolism (Embolus) 06/2017 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 08/2004
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2008 - 01/2007
2	Hyperhomocysteinemia 01/2007 - 10/2002
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2024
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2024
1	Hemophilia A (Haemophilia) 05/2023
1	Cerebral Small Vessel Diseases 01/2023
1	Calcinosis 01/2023
1	Sepsis (Septicemia) 01/2023
1	Aortic Dissection 11/2022
1	Fever (Fevers) 05/2021
1	Venous Thromboembolism 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2020
1	Wounds and Injuries (Trauma) 06/2019
1	Disease Susceptibility (Diathesis) 03/2019
1	Epilepsy (Aura) 01/2019
1	Pain (Aches) 01/2019

Drug/Important Bio-Agent (IBA)

18	AnticoagulantsIBA 01/2023 - 09/2007
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024 - 06/2009
6	Vitamin K FDA Link 12/2023 - 09/2015
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2011
5	HomocysteineIBA 01/2008 - 03/2002
4	Apolipoproteins E (ApoE)IBA 12/2023 - 02/2004
4	ORALIT (ORS)IBA 10/2021 - 02/2004
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 01/2016
3	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2021 - 01/2012
3	ApolipoproteinsIBA 01/2019 - 02/2004
3	CholesterolIBA 01/2016 - 06/2009
3	Prothrombin (Factor II)IBA 03/2015 - 03/2005
3	Folic Acid (Vitamin M)FDA LinkGeneric 02/2011 - 01/2004
2	Heparin (Liquaemin)FDA LinkGeneric 12/2023 - 09/2012
2	LipidsIBA 10/2023 - 06/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2023 - 01/2016
2	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2017
2	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 04/2014
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019 - 09/2012
2	Factor V (Coagulation Factor V)IBA 03/2015 - 03/2005
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 02/2011 - 01/2007
2	Fibrinogen (Factor I)FDA Link 01/2008 - 08/2004
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 12/2007 - 03/2005
2	Vitamin E FDA LinkGeneric 08/2004 - 01/2004
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 06/2024
1	Complement System Proteins (Complement)IBA 12/2023
1	ElastinIBA 01/2023
1	Oral ContraceptivesIBA 01/2023
1	CollagenIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Adenosine DeaminaseIBA 01/2023
1	C-Reactive ProteinIBA 10/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2022
1	Oxygen (Dioxygen)IBA 05/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	SteroidsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2020
1	parthenolideIBA 01/2019
1	MagnesiumIBA 01/2019
1	TabletsIBA 01/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2018
1	Protein CIBA 01/2018
1	ThrombomodulinIBA 01/2018
1	Endothelial Protein C ReceptorIBA 01/2018
1	activated protein C receptorIBA 01/2018
1	RivaroxabanIBA 11/2017
1	apixabanIBA 11/2017
1	Dabigatran FDA Link 11/2017

Therapy/Procedure

23	Therapeutics 12/2023 - 01/2007
9	Thrombectomy 01/2023 - 03/2017
7	Secondary Prevention 01/2022 - 05/2009
2	Thrombolytic Therapy 01/2020 - 01/2012
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2023
1	Musculoskeletal Manipulations (Manipulative Therapy) 06/2019